Derm3- Autoimmune

  1. What are the most common autoimmune skin diseases on dogs are cats? (2)
    pemphigus foliaceus (PF) and discoid lupus erythematosus (DLE)
  2. How does autoimmunity occur? (4)
    exposure to previously hidden antigens, change in T cell activity (loss of suppression or auto-reactive response), antigen mimicking (infectious agents, drugs), genetic influences
  3. With PF, autoantibodies are _______ and are directed against ___________.
    IgG; desmocollins (part of the desmosomes)
  4. How does acantholysis occur with PF?
    IgG binds to desmocollins, causing the release of enzymes that degrade the desmosomes
  5. Pemphigus is also seen in __(2)__; these diseases should be differentials and can be ruled out by __________.
    suppurative skin disease and dermatophytosis caused by Trichophyton mentagrophytes; biopsy
  6. What is the hallmark of pemphigus diseases?
    acantholytic keratinocytes- immature, detached keratinocytes
  7. What are the forms of pemphigus? (2)
    • Superficial: foliaceus/erythematosus; lesion forms underneath the stratus corneum or within stratum granulosum
    • Deep: vulgaris; lesion forms just above the basal cell layer
  8. What are the most common complaints with PF and p. vulgaris, respectively?
    • PF: crusting
    • PV: vesicles
  9. What are primary lesions of PF? (1)
    pustules (rupture very easily, usually don't see this by the time they come in)
  10. What are secondary lesions of PF? (6)
    crusts, scales, alopecia, erosions, erythema, +/- pruritus variable [this is usually what we see clinically]
  11. What is the distribution of lesions with PF? (6)
    muzzle (dorsal aspect), pinnae, footpads (hyperkeratotic, crusty), paronychia (more common in cats), general distribution, [very rarely] oral mucosa
  12. What are your differentials that may look like PF? (8)
    bacterial folliculitis, dermatophytosis, demodicosis, P. erythematosus, DLE, superficial necrolytic dermatitis, zinc responsive dermatosis, cutaneous lymphoma
  13. There is crusting and involvement of the footpads. What are your differentials? (3)
    PF, superficial necrolytic dermatitis, zinc responsive dermatosis
  14. What are skin cytology findings with PF? (3)
    multiple acantholytic keratinocytes, non-degenerate neutrophils, +/- eosinophils
  15. How is a diagnosis of PF confirmed?
    biopsy- subcorneal or intraepidermal pustules with acantholytic keratinocytes
  16. Benign form of superficial pemphigus that has similarities to DLE.
    pemphigus erythematosus
  17. P. erythematosus is usually localized to the ____(3)_____.
    face and pinna and nasal planum
  18. PF has _______ ANA (anti-nuclear antibodies); PE has _______ ANA titers.
    negative; negative or low (non-diagnostic)
  19. Lesions with p. erythematosus are aggravated by _________.
    UV light
  20. What is different between localization of PF and PE?
    PE often involves the actual nasal planum and nose; PE stays localized to the face usually
  21. Secondary lesions of PE. (4)
    crusts, erosion, alopecia, erythema
  22. Primary lesion of PE.
    pustules (not usually present)
  23. Describe the onset of PE. (2)
    gradual onset, lesions worse with UV exposure
  24. Describe histo findings with PE. (3)
    subcorneal or intraepidermal pustules, basal keratinocytes vacuolization, and presence of apoptotic cells in basal layer
  25. The ulcerative, deep, and most severe form of pemphigus.
    pemphigus vulgaris
  26. What are common seconadary lesions with PV? (4)
    erosions, deep ulcers, crusts, pain
  27. What non-dermatologic signs are present with PV? (3)
    pyrexia, anorexia, depression
  28. Describe the distribution of PV. (4)
    oral cavity (almost all cases), mucocutaneous junctions (eyes, mouth, genitals, anus), paronychia, frictional areas (axillae, inguinal)
  29. With which form of pemphigus do we see systemic signs?
    pemphigus vulgaris
  30. Cytologic findings with PV. (2)
    acantholytic keratinocytes and neutrophils
  31. What are histo findings with PV? (3)
    suprabasilar acantholysis and cleft forming vesicles or pustules containing acantholytic keratinocytes, neutrophils
  32. What is the characteristic finding on histo for PV?
    tombstone appearance of basal cells
  33. When are general principals of therapy for pemphigus? (3)
    lifelong (will be on drugs for life), immune suppression, can be controlled/ go into remission with appropriate therapy
  34. What are topical therapies that can be adjunctive treatments for pemphigus? (3)
    waterproof sunscreen (DLE, SLE, PE), vitamin E (DLE, SLE), topical corticosteroids
  35. Why is Vitamine E used as adjunctive treatment for SLE and SLE? What is important to remember about this supplement?
    antioxidant that stabilizes lysosomes; lag phase 6-12 weeks, so give it time to work
  36. What antibiotics are used to control autoimmune skin diseases? (4) How does this work?
    tetracycline (Doxycycline, Minocycline), Niacinamide; unknown MOA- inhibits neutrophil chemotaxis and release of proteases
  37. What topical steroid is good for long term use?
    hydrocortisone 1-2%
  38. What is the most effective steroid for use in cats?
    Triamcinolone
  39. What oral steroids are commonly used in dogs with autoimmune skin diseases? (3)
    prednisone, prednisolone, dexamethasone
  40. What is the MOA of Azathioprine?
    interferes with synthesis of nucleic acids, cytotoxic to T cells
  41. How is Azathioprine used?
    can be used as glucocorticoid sparing agent (to allow you to decrease steroid dose) or as sole therapy
  42. Azathioprine is contraindicated in __________.
    cats (b/c causes severe myelosuppression)
  43. What is the MOA of Chloambucil?
    alkylating agent, affects crosslinking of DNA
  44. Is Chlorambucil safe in cats?
    yes
  45. What is the MOA of cyclosporine and tacrolimus?
    immunosuppresant agents that suppress cytokine production (IL-2) and T cell proliferation [note: tacrolimus is topical]
  46. What is the MOA of mycophenelate mofetil?
    inhibits inosine monophosphate dehydrogenase, which is the rate limiting enzyme in certain DNA synthesis--> inhibits proliferative responses of T and B cells
  47. With DLE, _________ is affected; it is exacerbated by __________.
    only skin; UV light
  48. How do DLE lesions usually start? How can they progress?
    depigmentation and erythema of the planum nasale; may progress to erosions, ulcers, scaling, and crusts; lesions heal with a scar
  49. What is the distribution of lesions with DLE? (5)
    often limited to planum nasale and dorsal aspect of muzzle; may include mucocutaneous junctions, scrotum, pinnae
  50. What are differential diagnoses that may look like DLE? (4)
    PE, PE, dermatomyositis, zinc responsive dermatosis
  51. What are clinical signs of DLE? (5)
    depigmentation, crusting, ulcers, erythema, and crusts on the nose
  52. How do you diagnose DLE?
    Biopsy non-ulcerated, depigmented lesions: interface dermatitis characterized by hydropic-vcuolar changes at the BM and basal cell layer
  53. How do you treat DLE? (7)
    tacrolimus, doxycyline, niacinamide, cyclosporine, glucocorticoids, Vit E, sunscreen
  54. Ulcerative dermatitis affecting predominantly the ventrum of Shelties, Collies, +/- Border Collies.
    vesicular cutaneous lupus erythematosus
  55. Where are lesions associated with VCLE usually located? (2)
    mucocutaneous junctions and concave aspect of pinnae
  56. How has VCLE been managed? (8)
    glucocorticoid/azathioprine, doxycycline, cyclosporine, tetracycline/niacinamide, tacrolimus, sun avoidance
  57. Exfoliative cutaneous lupus erythematosus occurs in ____________; associated lesions include...(5)
    german short-haired pointers; scaling, alopecia, erythema, erosions, ulcers
  58. What is the distribution of lesions with exfoliative cutaneous lupus erythematosus? (4)
    muzzle, pinnae, dorsum, may become generalized
  59. How is exfoliated cutaneous lupus erythematosus managed, and how does it respond?
    steroids; progressive and poorly responsive to treatment
  60. Describe SLE.
    generalized connective tissue disorder that usually involves many organ systems
  61. What characterizes SLE?
    presence of anti-nuclear antibodies (ANAs)
  62. What is the pathogenesis of SLE?
    viral, genetic, and immunological factors have been postulated as etiologies--> multiple autoantibodies produced  and are responsible for clinical signs
  63. What lesions might be present as cutaneous manifestations of SLE? (7)
    macropapular, discoid, pruritic, urticarial, vesiculobullous, or seborrheic eruptions, depigmentation****
  64. Where are lesions usually located with SLE?
    anywhere- usually symmetrical
  65. What are clinical signs associated with SLE? (5)
    polyarthritis, skin lesions, glomerulonephritis, hemolytic anemia, thrombocytopenia
  66. How is SLE diagnosed? (6)
    Biopsy: interface dermatitis, vacuolar changes of the basal cells, vesicles and ulcers, thickened BM, individual apoptotic keratinocytes; ANA positive (90% of cases)
  67. What is the prognosis for SLE?
    guarded to good, may have periods of remission; guarded if glomerulonephritis is present
  68. 3 common diseases that are difficult to control and may ultimately lead to euthanasia (thus, life-threatening)?
    AD, canine generalized demodicosis, otitis externa/media
  69. What canine generalized demodex cases are hardest to manage and why?
    cases with concurrent allergies because allergy medications suppress the immune system, which is contraindicated when treating demodex
  70. What systemic diseases have skin manifestations? (5)
    hypothyroidism, hyperadrenocorticism, paraneoplastic syndromes (thymoma, pancreatic adenocarcinoma, paraneoplastic pemphigus)
  71. Describe thymoma-associated exfoliative dermatosis. (6)
    severe scaling and erythema, alopecia on head/neck/pinnae, anorexia/lethargy (systemic signs), respiratory signs, OLDER CAT RED FLAG (esp if never had skin dz before)
  72. How do you diagnose thymoma associated exfoliative dermatosis?
    • skin biopsy: interface dermatitis with exocytosis of lymphocytes, apoptotic keratinocytes, satellitosis, marked hyperkeratosis, absent sebaceous glands
    • rads: mediastinal mass
  73. What neoplasias are associated with paraneoplastic alopecia? (3)
    pancreatic adenocarcinoma, bile duct carcinoma, hepatocellular carcinoma
  74. What is "glistening skin" with alopecia characteristic of?
    paraneoplastic alopecia
  75. What drugs are most commonly associated with cutaneous adverse drug reaction? (5)
    sulfonamides, penicillins, cephalosporins, levasimole, dietyl carbamazine
  76. What ist he postulated pathogenesis of erythema multiforme? (6)
    drug reactions, bacterial infections, food adverse reactions, neoplasia, parvovirus, herpes?
  77. What is the clinical presentation of erythema multiforme? (5)
    target lesions (more variable in animals than people), erythematous macules, urticarial plaques, vesicles, ulcers
  78. How do you diagnose erythema multiforme?
    biopsy
  79. How do you manage erythema multiforme? (5)
    mild-none, glucocorticoids, azathioprine, cyclosporine, pentoxifylline
  80. Toxic epidermal necrolysis is __________ that is usually associated with _________.
    extensive "vesiculo-bullous" and ulcerative; drug reactions
  81. How do you diagnose toxic epidermal necrolysis? (2)
    • nikolsky sign: gentle skin manipulation results in sloughing
    • biopsy
  82. How do you manage toxic epidermal necrolysis? (4)
    withdrawal suspected drug, fluid therapy, wound management, immunosuppression (caution if infection)
  83. Cutaneous reaction pattern caused by diseases where blood vessel walls are the target of an inflammatory response.
    cutaneous vasculitis
  84. Lesions associated with cutaneous vasculitis. (7)
    purpura, hemorrhagic bullae, necrosis, ulcers, urticaria, atrophic skin, alopecia
  85. What are common locations for cutaneous vasculitis? (8)
    paws, pinnae, low legs, claws, lips, tail, scrotum, oral mucosa
  86. How do you diagnose cutaneous vasculitis? (3)
    history of drugs and vaccines, rule out infectious diseases, biopsy
  87. How do you manage cutaneous vasculitis? (5)
    address primary cause, doxycycline/niacinamide, pentoxifylline, tacrolimus, immunosuppression
Author
Mawad
ID
318107
Card Set
Derm3- Autoimmune
Description
vetmed derm3
Updated